Search for: "KING PHARMACEUTICALS, INC."
Results 61 - 80
of 211
Sort by Relevance
|
Sort by Date
7 Nov 2014, 5:52 am
King-Washington v. [read post]
3 May 2014, 8:56 am
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
10 Jan 2014, 8:18 am
” King Pharmaceuticals, Inc. v. [read post]
21 Nov 2013, 12:13 pm
The FDA’s brief cited Sigma-Tau Pharmaceuticals, Inc. v. [read post]
15 Nov 2013, 11:34 am
Pfizer, Inc., 914 F. [read post]
23 Sep 2013, 3:03 pm
Continue reading »Follow Above the Law on Twitter or become a fan on Facebook.Tags: Biglaw, Drinking, Hunton & Williams, Insider Trading, Intellectual Property, King Pharmaceuticals Inc., Klein Financial Services, Lawyer Drinking, M&A, Mergers and Acquisitions, Michael Shechtman, Partner Issues, Partners With Issues, Pfizer, Robert M. [read post]
19 Sep 2013, 12:35 pm
Chaudhary worked in various human service organizations including the Young Adult Institute in Queens, NY, the Girls Incorporated of the Greater Capital Region, and Clearview Center, Inc. in Albany, NY. [read post]
12 Sep 2013, 7:37 am
Ct. 2567 (2011), and Mutual Pharmaceutical Co. v. [read post]
16 Jul 2013, 6:05 am
Medtronic, Inc., 2013 U.S. [read post]
28 Jun 2013, 6:01 pm
Praxair Canada Inc., [1998] O.J. [read post]
11 Mar 2013, 12:49 pm
Mar. 5, 2013), the plaintiffs were qui tam relators who’d sparked investigations by state AGs into alleged False Claims Act violations by the pharmaceutical manufacturer, Abbot Products, Inc., which was later acquired by Solvay Pharmaceuticals, Inc.. [read post]
30 Jan 2013, 1:47 pm
Ohio 2010) (applying Ohio law); King v. [read post]
28 Jan 2013, 11:46 am
Ortho Pharmaceutical Corp., 770 F. [read post]
16 Nov 2012, 1:50 pm
Sharp Memorial Hospital, Inc., 264 Cal. [read post]
2 Nov 2012, 11:58 am
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
15 Oct 2012, 8:13 am
The evidence showed that from 1996 through September 2000, Edwards, the founder of ETS Payphones, Inc. [read post]
29 Aug 2012, 3:15 am
Ranbaxy Pharmaceuticals, Inc., 336 F.3d 1322, 1330 (Fed. [read post]
9 Aug 2012, 5:00 am
Nittany Pharmaceuticals (?) [read post]
11 Jul 2012, 10:22 am
Michael Petty, the former vice president of development and regulatory law at biotechnology company Amgen Inc., joins King & Spalding in its Washington office. [read post]
10 Jun 2012, 1:09 pm
In some instances, especially in studies pharmaceutical adverse outcomes, there is the danger that the hypothesized outcome is also a feature of the underlying disease being treated. [read post]
